Skip to main content
 

For over a decade, HOST Therabiomics has worked to apply our understanding of the human host+biome interaction to prevent, modify, and treat disease. Our dedicated scientific leadership team has unlocked the microbiome’s potential to promote health by leveraging a targeted, evidence-based strategy for developing microbiome-based therapeutics.

To date, we have been granted more than 270 patents globally covering nine patent families for our novel technologies, and our data has been published in scientific peer-review journals. If you would like to learn more about these publications and patents, please contact us.

Learn More